Total Payments
$117,827
2024 Payments
$14,024
Companies
73
Transactions
384
Medicare Patients
11,688
Medicare Billing
$3.5M
Payment Breakdown by Category
Consulting$81,033 (68.8%)
Other$21,845 (18.5%)
Food & Beverage$7,563 (6.4%)
Travel$6,463 (5.5%)
Education$922.84 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $81,033 | 51 | 68.8% |
| Grant | $10,000 | 1 | 8.5% |
| Food and Beverage | $7,563 | 275 | 6.4% |
| Honoraria | $7,320 | 6 | 6.2% |
| Travel and Lodging | $6,463 | 32 | 5.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,525 | 6 | 3.8% |
| Education | $922.84 | 13 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $20,162 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $12,247 | 4 | $0 (2024) |
| GENZYME CORPORATION | $11,351 | 21 | $0 (2024) |
| Lilly USA, LLC | $10,219 | 11 | $0 (2024) |
| Kite Pharma, Inc. | $7,606 | 13 | $0 (2022) |
| PFIZER INC. | $5,970 | 16 | $0 (2024) |
| Acrotech Biopharma Inc. | $4,724 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $4,719 | 22 | $0 (2024) |
| Exelixis Inc. | $4,089 | 12 | $0 (2023) |
| Incyte Corporation | $3,433 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,024 | 77 | Acrotech Biopharma Inc. ($4,688) |
| 2023 | $13,933 | 113 | AstraZeneca Pharmaceuticals LP ($4,019) |
| 2022 | $31,429 | 65 | Lilly USA, LLC ($10,067) |
| 2021 | $8,568 | 19 | Regeneron Healthcare Solutions, Inc. ($2,100) |
| 2020 | $13,686 | 23 | AstraZeneca Pharmaceuticals LP ($7,328) |
| 2019 | $14,915 | 40 | Kite Pharma, Inc. ($4,566) |
| 2018 | $20,111 | 37 | GENZYME CORPORATION ($6,720) |
| 2017 | $1,160 | 10 | Incyte Corporation ($354.02) |
All Payment Transactions
384 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,675.00 | General |
| 12/16/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $180.60 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $149.10 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Oncology | ||||||
| 11/15/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/08/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $398.96 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $162.16 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $219.69 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $186.67 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Biological | ||||||
| 10/25/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | Invivyd Inc | PEMGARDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: HEMATOLOGY | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.97 | General |
| Category: Oncology | ||||||
| 09/11/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Oncology | ||||||
| 08/29/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: HEMATOLOGY | ||||||
| 08/22/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $16.73 | General |
| Category: Oncology | ||||||
| 08/05/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,843 | 138,217 | $3.4M | $875,669 |
| 2022 | 33 | 2,881 | 159,285 | $3.8M | $910,736 |
| 2021 | 30 | 2,794 | 146,808 | $3.0M | $836,170 |
| 2020 | 42 | 3,170 | 138,748 | $3.6M | $917,955 |
Total Patients
11,688
Total Services
583,058
Medicare Billing
$3.5M
Procedure Codes
139
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 98 | 17,460 | $1.0M | $321,342 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 473 | 1,033 | $366,715 | $101,826 | 27.8% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 42 | 39,000 | $468,000 | $92,130 | 19.7% |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | Office | 2023 | 11 | 2,772 | $249,480 | $69,900 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 436 | 708 | $173,460 | $47,735 | 27.5% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 24 | 2,800 | $184,800 | $45,959 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 197 | 197 | $133,369 | $32,812 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 103 | 230 | $109,250 | $32,367 | 29.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 32 | 246 | $115,374 | $25,891 | 22.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 114 | 362 | $95,206 | $22,658 | 23.8% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 39 | 59,160 | $189,312 | $22,629 | 12.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 104 | 273 | $64,701 | $14,489 | 22.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 49 | 383 | $20,682 | $4,947 | 23.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 32 | 47 | $7,050 | $4,582 | 65.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 230 | 545 | $4,905 | $4,578 | 93.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 239 | 597 | $14,328 | $4,543 | 31.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 64 | 320 | $15,040 | $3,799 | 25.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 38 | 51 | $5,202 | $3,419 | 65.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 31 | 131 | $13,493 | $3,037 | 22.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 21 | $13,755 | $3,023 | 22.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 15 | 53 | $12,084 | $2,768 | 22.9% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 32 | 111 | $10,323 | $2,261 | 21.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 107 | 200 | $6,400 | $2,070 | 32.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 14 | 76 | $7,600 | $1,757 | 23.1% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 32 | 216 | $8,640 | $1,351 | 15.6% |
About Dr. Arun Bhandari, MD
Dr. Arun Bhandari, MD is a Hematology & Oncology healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730161878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arun Bhandari, MD has received a total of $117,827 in payments from pharmaceutical and medical device companies, with $14,024 received in 2024. These payments were reported across 384 transactions from 73 companies. The most common payment nature is "Consulting Fee" ($81,033).
As a Medicare-enrolled provider, Bhandari has provided services to 11,688 Medicare beneficiaries, totaling 583,058 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Annapolis, MD
- Active Since 11/15/2005
- Last Updated 10/04/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1730161878
Products in Payments
- ZEJULA (Drug) $13,025
- JEVTANA (Drug) $9,078
- Yescarta (Drug) $7,606
- LYNPARZA (Drug) $6,376
- LIBTAYO (Biological) $4,761
- BELEODAQ (Drug) $4,724
- IMFINZI (Biological) $4,440
- Cabometyx (Drug) $4,062
- CALQUENCE (Drug) $2,533
- JEMPERLI (Biological) $2,272
- Bavencio (Biological) $2,212
- PEMGARDA (Biological) $2,100
- SARCLISA (Biological) $1,914
- ULTOMIRIS (Biological) $1,873
- IMFINZI (Drug) $1,756
- REBLOZYL (Biological) $1,641
- XPOVIO (Drug) $1,550
- Vonjo (Drug) $1,500
- IBRANCE (Drug) $1,450
- TUKYSA (Drug) $1,398
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Annapolis
Carol Tweed, Md, MD
Hematology & Oncology — Payments: $129,960
Hematology & Oncology $129,960
Dr. Ravin Garg, M.d, M.D
Hematology & Oncology — Payments: $12,567
Hematology & Oncology $12,567
Dr. Peter Graze, M.d, M.D
Hematology & Oncology — Payments: $11,731
Hematology & Oncology $11,731
Dr. Jeanine Werner, M.d, M.D
Hematology & Oncology — Payments: $8,620
Hematology & Oncology $8,620
Dr. Stuart Selonick, M.d, M.D
Hematology & Oncology — Payments: $6,239
Hematology & Oncology $6,239
Dr. Benjamin Bridges, Md, MD
Hematology & Oncology — Payments: $4,035
Hematology & Oncology $4,035